United States · 
Who invested in Alladapt Immunotherapeutics?
Alladapt Immunotherapeutics's investors include Novartis and Hercules Capital.
United States · Funded startup
Who invested in Alladapt Immunotherapeutics
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2022, from 1 source
- Latest round
- Debt, $50MAug 2022
- Investors
- 2
The rounds
- Aug 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Alladapt Immunotherapeutics
How much has Alladapt Immunotherapeutics raised?
Alladapt Immunotherapeutics has raised $50M across 1 round since 2022.
When did Alladapt Immunotherapeutics last raise?
Alladapt Immunotherapeutics's most recent round was a Debt of $50M in Aug 2022.
What was Alladapt Immunotherapeutics's biggest round?
Its most recent round, $50M in Aug 2022, is also its largest on record.
Who backed Alladapt Immunotherapeutics first?
Alladapt Immunotherapeutics's first round on record, in Aug 2022, was backed by Novartis and Hercules Capital.
What stage is Alladapt Immunotherapeutics at?
Alladapt Immunotherapeutics's latest named round is a Debt, in Aug 2022.
Where is Alladapt Immunotherapeutics based?
Alladapt Immunotherapeutics is based in the United States.
Companies like Alladapt Immunotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.